M4284
CAS No. 1373346-85-0
M4284 ( M-4284;M 4284 )
产品货号. M11539 CAS No. 1373346-85-0
M4284 (M-4284) is a high-affinity biphenyl mannoside FimH inhibitor with HAI of 16 nM in hemagglutination assay.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥2292 | 有现货 |
|
10MG | ¥3686 | 有现货 |
|
25MG | ¥6099 | 有现货 |
|
50MG | ¥8586 | 有现货 |
|
100MG | ¥11583 | 有现货 |
|
500MG | ¥23166 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称M4284
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述M4284 (M-4284) is a high-affinity biphenyl mannoside FimH inhibitor with HAI of 16 nM in hemagglutination assay.
-
产品描述M4284 (M-4284) is a high-affinity biphenyl mannoside FimH inhibitor with HAI of 16 nM in hemagglutination assay; reduces intestinal colonization of genetically diverse UPEC isolates, while simultaneously treating UTI, without notably disrupting the structural configuration of the gut microbiota; reduces UTI89 levels in the gut and urinary tracts of mice.
-
同义词M-4284;M 4284
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Antibacterial
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number1373346-85-0
-
分子量460.48
-
分子式C23H28N2O8
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC1=C(C=CC(=C1)C2=CC(=CC(=C2)C(=O)NC)C(=O)NC)OC3C(C(C(C(O3)CO)O)O)O
-
化学全称N3,N5,3'-trimethyl-4'-(((3S,4R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-[1,1'-biphenyl]-3,5-dicarboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Spaulding CN, et al. Nature. 2017 Jun 22;546(7659):528-532.
2. Jarvis C, et al. ChemMedChem. 2016 Feb 17;11(4):367-73.
3. Han Z, et al. J Med Chem. 2012 Apr 26;55(8):3945-59.
2. Jarvis C, et al. ChemMedChem. 2016 Feb 17;11(4):367-73.
3. Han Z, et al. J Med Chem. 2012 Apr 26;55(8):3945-59.
产品手册
关联产品
-
Chitosan
Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine.
-
Resazurin sodium sal...
Resazurin sodium salt is a blue non-fluorescent dyeis widely used as a metabolic indicator for living cells.
-
Taniborbactam
Taniborbactam is a novel beta-lactamase inhibitor for the treatment of bacterial infections.